Showing results (71-80 of 96) with videos related to
Sort By:
Pageof 10
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3)Martin Forster, Allan Hackshaw, Tommaso De Pas, et al.BMJ Open|March 19, 2020
Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocolAnthony Kong, James Good, Amanda Kirkham, et al.BMJ Open|April 19, 2018
Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancerJohn Conibear, Brendan Chia, Yenting Ngai, et al.ESMO Open|June 28, 2019
Prospective analysis of 895 patients on a UK Genomics Review BoardDavid Allan Moore, Marina Kushnir, Gabriel Mak, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 18, 2006
Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized studyEugene V McCloskey, Monique Beneton, Diane Charlesworth, et al.Clinical Lung Cancer|May 26, 2021
A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung CancerLauren Averett Byers, Alejandro Navarro, Eric Schaefer, et al.Investigational New Drugs|March 11, 2021
Efficacy and safety of lurbinectedin and doxorubicin in relapsed small cell lung cancer. Results from an expansion cohort of a phase I studyMaría Eugenia Olmedo, Martin Forster, Victor Moreno, et al.Cancers|September 13, 2025
Predictors and Outcomes of Non-Small Cell Lung Carcinoma Patients Following Severe Immune Checkpoint Inhibitor Toxicity: A Real-World UK Multi-Centre StudyUmair Mahmood, Eleni Josephides, Meenali Chitnis, et al.Therapeutic Advances in Medical Oncology|November 12, 2020
COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort studyValerie E Crolley, Daire Hanna, Nalinie Joharatnam-Hogan, et al.European Journal of Cancer (Oxford, England : 1990)|December 18, 2024
Hydroxychloroquine in combination with platinum doublet chemotherapy as first-line treatment for extensive-stage small cell lung cancer (Study 15): A randomised phase II multicentre trialSiow Ming Lee, Madeleine Hewish, Samreen Ahmed, et al.Pageof 10